These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27034780)

  • 1. Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it?
    Bull JJ
    Virus Evol; 2015 Jan; 1(1):. PubMed ID: 27034780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistastic Interactions within the Junín Virus Envelope Glycoprotein Complex Provide an Evolutionary Barrier to Reversion in the Live-Attenuated Candid#1 Vaccine.
    York J; Nunberg JH
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradicating infectious disease using weakly transmissible vaccines.
    Nuismer SL; Althouse BM; May R; Bull JJ; Stromberg SP; Antia R
    Proc Biol Sci; 2016 Oct; 283(1841):. PubMed ID: 27798311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The double-edged sword: How evolution can make or break a live-attenuated virus vaccine.
    Hanley KA
    Evolution (N Y); 2011 Dec; 4(4):635-643. PubMed ID: 22468165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.
    Davis EH; Beck AS; Strother AE; Thompson JK; Widen SG; Higgs S; Wood TG; Barrett ADT
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological safety concepts of genetically modified live bacterial vaccines.
    Frey J
    Vaccine; 2007 Jul; 25(30):5598-605. PubMed ID: 17239999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of a live-attenuated eastern equine encephalitis virus vaccine through informed mutation of virulence determinants.
    Trobaugh DW; Sun C; Dunn MD; Reed DS; Klimstra WB
    PLoS Pathog; 2019 Feb; 15(2):e1007584. PubMed ID: 30742691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
    J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial Approaches to Viral Attenuation.
    Paff ML; Jack BR; Smith BL; Bull JJ; Wilke CO
    mSystems; 2018; 3(4):. PubMed ID: 30073203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionarily stable attenuation by genome rearrangement in a virus.
    Cecchini N; Schmerer M; Molineux IJ; Springman R; Bull JJ
    G3 (Bethesda); 2013 Aug; 3(8):1389-97. PubMed ID: 23797106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.
    Zhou B; Meliopoulos VA; Wang W; Lin X; Stucker KM; Halpin RA; Stockwell TB; Schultz-Cherry S; Wentworth DE
    J Virol; 2016 Oct; 90(19):8454-63. PubMed ID: 27440882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
    Yang D; Li XF; Ye Q; Wang HJ; Deng YQ; Zhu SY; Zhang Y; Li SH; Qin CF
    Vaccine; 2014 May; 32(23):2675-81. PubMed ID: 24709585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions.
    Virnik K; Ni Y; Berkower I
    Vaccine; 2013 Apr; 31(17):2119-25. PubMed ID: 23474312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects of Next-Generation Vaccines for Bluetongue.
    van Rijn PA
    Front Vet Sci; 2019; 6():407. PubMed ID: 31824966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD; Firestone CY; Whitehead SS
    J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development.
    Tsetsarkin KA; Liu G; Volkova E; Pletnev AG
    mBio; 2017 Apr; 8(2):. PubMed ID: 28420742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
    Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of a Pathogenic
    Lartigue C; Valverde Timana Y; Labroussaa F; Schieck E; Liljander A; Sacchini F; Posthaus H; Batailler B; Sirand-Pugnet P; Vashee S; Jores J; Blanchard A
    mSphere; 2019 May; 4(3):. PubMed ID: 31118296
    [No Abstract]   [Full Text] [Related]  

  • 20. Transmissible Viral Vaccines.
    Bull JJ; Smithson MW; Nuismer SL
    Trends Microbiol; 2018 Jan; 26(1):6-15. PubMed ID: 29033339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.